Apr 05, 2017 12:01 pm UTC| Business
WASHINGTON and REDWOOD CITY, Calif., April 05, 2017 -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and...
Apr 05, 2017 12:01 pm UTC| Business
WASHINGTON and REDWOOD CITY, Calif., April 05, 2017 -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and...
Apr 05, 2017 12:01 pm UTC| Business
LA JOLLA, Calif., April 05, 2017 -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced the presentation of...
Apr 05, 2017 12:01 pm UTC| Business
LA JOLLA, Calif., April 05, 2017 -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced the presentation of...
Sigma Labs Releases Alpha Version of Its OEM Developer’s Kit for PrintRite3D®
Apr 05, 2017 12:01 pm UTC| Business
SANTA FE, N.M., April 05, 2017 -- Sigma Labs, Inc. (NASDAQ:SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today announced the release of its OEM Developer's...
Sigma Labs Releases Alpha Version of Its OEM Developer’s Kit for PrintRite3D®
Apr 05, 2017 12:01 pm UTC| Business
SANTA FE, N.M., April 05, 2017 -- Sigma Labs, Inc. (NASDAQ:SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today announced the release of its OEM Developer's...
Fortress Biotech Announces Orphan Drug Designations for CAEL-101 in Amyloidosis
Apr 05, 2017 12:01 pm UTC| Business
NEW YORK, April 05, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...